Oncoimmunology. 2012 Jul 1;1(4):541-543.

A novel facet of tumor suppression by p53: Induction of tumor immunogenicity.

Li H, Lakshmikanth T, Carbone E, Selivanova G.

Source

Department of Microbiology; Tumor and Cell Biology; Karolinska Institutet; Stockholm, Sweden.

Abstract

Pharmacological reactivation of the p53 tumor suppressor is a promising strategy for anti-cancer therapy due to its high potential to elicit apoptosis or growth arrest in cancer cells. Recently we uncovered the mechanism of activation of the innate immune response by p53 upon its activation by small molecules.

PMID:: 22754780; [PubMed]
PMCID:: PMC3382884

Free PMC Article

Images from this publication.See all images (1)Free text

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

PubReader: The way to read articles has evolved, no matter what device you use.

Related citations in PubMed

Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2. [Cell Cycle. 2011]
Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2.
Li H, Lakshmikanth T, Garofalo C, Enge M, Spinnler C, Anichini A, Szekely L, Kärre K, Carbone E, Selivanova G. Cell Cycle. 2011 Oct 1; 10(19):3346-58. Epub 2011 Oct 1.
A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells. [PLoS One. 2012]
A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells.
Dai F, Chen Y, Song Y, Huang L, Zhai D, Dong Y, Lai L, Zhang T, Li D, Pang X, et al. PLoS One. 2012; 7(12):e52162. Epub 2012 Dec 27.
Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer. [Mol Cancer Ther. 2008]
Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer.
Shangary S, Ding K, Qiu S, Nikolovska-Coleska Z, Bauer JA, Liu M, Wang G, Lu Y, McEachern D, Bernard D, et al. Mol Cancer Ther. 2008 Jun; 7(6):1533-42.
Review [Pharmacological activation of tumor suppressor, wild-type p53 as a promising strategy to fight cancer]. [Postepy Hig Med Dosw (Online)....]
Review [Pharmacological activation of tumor suppressor, wild-type p53 as a promising strategy to fight cancer].
Sznarkowska A, Olszewski R, Zawacka-Pankau J. Postepy Hig Med Dosw (Online). 2010 Aug 20; 64:396-407. Epub 2010 Aug 20.
Review Pharmacological reactivation of mutant p53: from protein structure to the cancer patient. [Oncogene. 2010]
Review Pharmacological reactivation of mutant p53: from protein structure to the cancer patient.
Wiman KG. Oncogene. 2010 Jul 29; 29(30):4245-52. Epub 2010 May 24.

See reviews... See all...

Cited by 1 PubMed Central article

A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells. [PLoS One. 2012]
A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells.
Dai F, Chen Y, Song Y, Huang L, Zhai D, Dong Y, Lai L, Zhang T, Li D, Pang X, et al. PLoS One. 2012; 7(12):e52162. Epub 2012 Dec 27.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

A novel facet of tumor suppression by p53: Induction of tumor immunogenicity.
A novel facet of tumor suppression by p53: Induction of tumor immunogenicity.
Oncoimmunology. 2012 Jul 1;1(4):541-543.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

A novel facet of tumor suppression by p53: Induction of tumor immunogenicity.

Source

Abstract

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information